| |
|
|
|
Therapix Biosciences Ltd.  
|
|
2.96 0.04 (0.01%) |
09-17 15:59 |
|
Open: |
2.98 |
Pre close: |
2.92 |
Target:
|
3.49
|
|
High: |
2.98 |
Low: |
2.9 |
Resistance:
|
2.99
3.49
|
|
Volume: |
22,443 |
Market Cap: |
13M |
Support:
|
2.44
 2.10
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.87
|
MACD |
MACD(12,26):
|
0.13 |
|
MA(20): |
2.57 |
Signal(12,26,9): |
0.08 |
|
MA(100): |
2.71  |
Stochastic Oscillator |
%K(14,3):
|
90.96 |
|
MA(250): |
3.93 |
%D(3): |
89.46 |
|
Average Volume(K) |
3-Month: |
11387
|
52-Week |
High:
|
9.30 |
|
10-Days: |
5903 |
Low: |
2.04 |
|
RSI |
RSI(14):
|
70.49 |
Change(%): |
-26.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.569 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
3.51 |
|
EPS Est. Current Year |
-1.520 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
4.02 |
|
EPS Est. Next Year |
-2.130 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.08 |
|
EPS Est. Next Quarter |
-0.550 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-2.158 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
188 |
|
Book Value (p.s.) |
0.050 |
EBITDA (p.s.) |
-2.516 |
P/E |
-1.15 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
59.20 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
